Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 34,248	$ 41,786
Prepaid expenses and other current assets	3,717	3,734
Total Current Assets	37,965	45,520
Non-Current Assets
Property and equipment, net	301	345
Restricted cash	100	99
Right of use asset	1,956	1,199
In-process research and development	19,483	19,150
Goodwill	5,621	5,525
Deposits and other assets	23	23
Total Assets	65,449	71,861
Current Liabilities:
Accounts payable	741	915
Accrued expenses	1,826	1,496
Accrued employee benefits	1,070	1,403
Contingent consideration, current portion	4,978	2,973
Loans payable-current	67	57
Operating lease liability	452	216
Total Current Liabilities	9,134	7,060
Non-current Liabilities
Non-current contingent consideration	5,773	7,211
Loan Payable - Long term	153	221
Deferred tax liabilities, net	952	1,618
Operating lease liability - Long term	1,684	1,187
Total Liabilities	17,696	17,297
Commitments and Contingencies
Stockholders' Equity:
Common stock, $0.001 par value; 350,000,000 shares authorized, 17,762,010 issued and 17,041,777 outstanding at June 30, 2023 and 15,844,294 issued and 15,124,061 outstanding at December 31, 2022	18	16
Additional paid-in capital	346,176	343,750
Treasury stock at cost, 720,233 shares at June 30, 2023 and at December 31, 2022	(288)	(288)
Accumulated other comprehensive loss	(356)	(679)
Accumulated deficit	(300,531)	(290,969)
Total Stockholders' Equity	45,019	51,830
Total Liabilities Temporary Equity, and Stockholders' Equity	65,449	71,861
Series C convertible preferred stock
Temporary Equity
Convertible preferred stock	2,006	2,006
Series D convertible preferred stock
Temporary Equity
Convertible preferred stock	$ 728	$ 728